(Q39265337)

English

A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

A candidate gene study of serotonergic pathway genes and pain relief during treatment with escitalopram in patients with neuropathic pain shows significant association to serotonin receptor2C (HTR2C). (English)

1 reference

Europe PubMed Central

10 September 2017

neuropathic pain

0 references

0 references

1 reference

based on heuristic

inferred from title

Søren H Sindrup

object named as

Søren H Sindrup

7

0 references

object named as

Kim Brøsen

6

0 references

author name string

Charlotte Brasch-Andersen

1

1 reference

Europe PubMed Central

10 September 2017

Malik U Møller

2

1 reference

Europe PubMed Central

10 September 2017

Lene Christiansen

3

1 reference

Europe PubMed Central

10 September 2017

Mikael Thinggaard

4

1 reference

Europe PubMed Central

10 September 2017

Marit Otto

5

1 reference

Europe PubMed Central

10 September 2017

publication date

26 May 2011

1 reference

Europe PubMed Central

10 September 2017

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

10 September 2017

67

1 reference

Europe PubMed Central

10 September 2017

11

1 reference

Europe PubMed Central

10 September 2017

1131-1137

1 reference

Europe PubMed Central

10 September 2017

https://scigraph.springernature.com/pub.10.1007/s00228-011-1056-x

0 references

The evidence for pharmacological treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Antidepressants in the treatment of neuropathic pain

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Bad news from the brain: descending 5-HT pathways that control spinal pain processing

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Serotonergic modulation of spinal sensory circuits.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Candidate gene polymorphisms in the serotonergic pathway: influence on depression symptomatology in an elderly population

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Role of warfarin pharmacogenetic testing in clinical practice

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Genetic association studies to detect adverse drug reactions: abacavir hypersensitivity as an example

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Progress in genome-wide association studies of human height.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Pharmacogenetics of antidepressant response: an update

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Modification of human 5-HT(2C) receptor function by Cys23Ser, an abundant, naturally occurring amino-acid substitution.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI).

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

No relationship between the ins del polymorphism of the serotonin transporter promoter and pain perception in fibromyalgia patients and healthy controls

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Identification of functionally variant MDR1 alleles among European Americans and African Americans

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Impact of CYP2C19 phenotypes on escitalopram metabolism and an evaluation of pupillometry as a serotonergic biomarker.

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1056-X

21 January 2018

Identifiers

10.1007/S00228-011-1056-X

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39265337&oldid=1452206597"